Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-18-015878

SVP, General Counsel & Sec. sold 3,660 shares at $18.71 ($68,473)

  • SVP, General Counsel & Sec. acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Gulino Richard L. SVP, General Counsel & Sec. 2018-02-28 Grant or award +30,000 118,733 D
Gulino Richard L. SVP, General Counsel & Sec. 2018-03-01 Sale −3,660 $18.71 $68,473 115,073 D
Derivatives
Gulino Richard L. SVP, General Counsel & Sec. 2018-02-28 Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000 D
Open-market sales · 3,660 sh · avg $18.71 · $68,473
Loading xslF345X03/doc4.xml…